Injection Articles
Copaxone storage requirements relaxed
11 June 2007
Lilly reports benefits of Alimta in NSCLC
11 June 2007
Activist group releases Gardasil AE data
4 June 2007
Japan stock market week to May 28, 2007
4 June 2007
Roche's Mircera gets nod from CHMP
4 June 2007
UCB's Cimzia shows efficacy at 80 weeks
28 May 2007
Sosei completes AD 923 pharmacokinetic study
28 May 2007
Combined Velcade plus Doxil gets FDA OK for MM
28 May 2007
FDA approves Lovenox sNDA for STEMI
28 May 2007
Tovaxin trial completes patient enrollment
28 May 2007
Japanese drugstore generic drug research
21 May 2007
"Not approvable" letter for Acthar sNDA
21 May 2007
FDA asks for more data on Emend injection
21 May 2007
Japan stock market week to May 7, 2007
14 May 2007
MGI and Helsinn submit Aloxi sNDA
14 May 2007
ACT achieves vascular repair with hES cells
14 May 2007
Nautilus raises $11.3M to fund lead products
7 May 2007
FDA approves Sanofi's Lantus SoloStar
7 May 2007
Pharmacyclics files Xcytrin with US FDA
30 April 2007
Pharmion's oral azacitidine advances
30 April 2007
Clexane more effective than UFH in VTE
30 April 2007
Gilead's 1st-qtr 2007 net income sky-rockets 55%
30 April 2007
MGI's 1st-qtr 2007 net income rises to $83.2M
30 April 2007
GSK's Arixtra and Seretide/Advair approved in Japan
23 April 2007
Genta to initiate new Ph III of Genasense
23 April 2007
Amylin's 1st-qtr 2007 net loss narrows 27.2%
23 April 2007
FDA approves new Risperdal Consta dose
23 April 2007
Organon
16 April 2007
Pulmonary drug-delivery market to reach $34.5B by 2010
16 April 2007
No weight gain for "majority" on Levemir
16 April 2007
Ph II trial of belinostat and Velcade initiated
2 April 2007
TopoTarget in-licenses Zemab from Novartis
19 March 2007
Novo Nordisk growing in Japan
19 March 2007
"Give up on polio eradication," WHO told
12 March 2007
New Vaprisol indication ushers in age of aquaresis
12 March 2007
Cytogen's 4th-qtr 2006 losses up 85.4%
12 March 2007
Nautilus files Belerofon IND
5 March 2007
$575M shortfall in polio eradication funding
5 March 2007
Biovitrum's FY 2006 net profit plummets 47.4%
5 March 2007
US FDA approves King's Bicillin production plant
5 March 2007
Strong Ph I data for Teverelix LA
26 February 2007
Akzo Nobel's 2006 net income increases 20%
26 February 2007
Hylenex may have role in analgesia, says trial
26 February 2007
Strong Ph I/II data for Osiris' Chondrogen
19 February 2007
Bayer's Kogenate gets EU OK for use in surgery
19 February 2007
Alkermes reports $3M 4th-qtr 2006 net income
19 February 2007
MGI's 4th-qtr 2006 net loss narrows to $19.6M
19 February 2007
FDA priority review for Sanofi's Lovenox in STEMI
12 February 2007
Levemir demonstrates safety and efficacy
7 February 2007
Sangamo unveils Ph I ZFP data at ADA conf
7 February 2007
Exubera shows safety and efficacy
7 February 2007
Merck Serono debuts easypod injection device
5 February 2007
Alliance Boots in deal with Beijing Med-Pharm for GP Corp
5 February 2007
Crucell's PER.C6-based West Nile Vaccine good in trials
5 February 2007
Bayer stops non-CABG Trasylol studies
5 February 2007
Stock Commentary - New York week to Aug 15
29 January 2007
Pliva gets US OK for generic Zithromax
29 January 2007
J&J's 4th qtr 2006 EPS beats analysts' estimate
29 January 2007
Ortho Biotech seeks OK for Doxil/Velcade combo
29 January 2007
Orphan status for Hana's Marqibo
22 January 2007
Japan stock market week to Jan 15, 2007
22 January 2007
Astellas launches 100mg Mycamine
22 January 2007
GenVec gets FDA clearance for EUS TNFerade delivery
22 January 2007
Roche's NeoRecormon gets EU approval for weekly injection
15 January 2007
ThromboGenics initiates Ph IIb US trial
15 January 2007
A turnaround for SkyePharma with injectables unit sale for $82M
15 January 2007
Boeh Ingel enters $265M Nanobody R&D deal
15 January 2007
Cerepro Ph III trial gets DSMB go ahead
15 January 2007
Abraxis launches generic ondansetron injection in USA
8 January 2007
Astellas submits sNDA for Mycamine
8 January 2007
Ardana posts strong Ph II Teverelix LA data
22 December 2006
MGI/Helsinn's Aloxi meets Ph III endpoints
22 December 2006
Ardana's Invicorp launched in Denmark
22 December 2006
Bayer announces Trasylol label revisions
22 December 2006
AstraZeneca pays Cubist $10.25M up front for Asian right to Cubicin
18 December 2006
BioAlliance gets AFSSAPS ok for Ph II/III liver cancer trial
18 December 2006
PXD101 shows promise in Phase II MM trial
18 December 2006
QLT
11 December 2006
Neurobiological to step up Viprinex production
11 December 2006
FDA approves Abraxis' ANDA for generic combo antibiotic
4 December 2006
US FDA clears Teva's generic of GSK's Zofran
4 December 2006
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
